EFFECT OF NONSPECIFIC-BINDING TO PLASMA-PROTEINS ON THE ANTITHROMBIN ACTIVITIES OF UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN, AND DERMATAN SULFATE
B. Cosmi et al., EFFECT OF NONSPECIFIC-BINDING TO PLASMA-PROTEINS ON THE ANTITHROMBIN ACTIVITIES OF UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN, AND DERMATAN SULFATE, Circulation, 95(1), 1997, pp. 118-124
Background Nonspecific binding to plasma proteins decreases the anti-f
actor Xa (anti-Xa) activity of unfractionated heparin (UFH) but not th
at of low-molecular-weight heparin (LMWH). However, plasma proteins co
uld influence the antithrombin (anti-IIa) activity of LMWH. To explore
this possibility, we compared the effects of plasma proteins on the a
nti-IIa activities of UFH and LMWH. We also examined their effects on
the anti-IIa activity of dermatan sulfate (DS) because, like UFH, DS b
inds to plasma proteins. Methods and Results There was almost complete
recovery of anti-IIa activity when UFH, LMWH, or DS was added to plas
ma from each of 20 healthy volunteers. The addition of a chemically mo
dified heparin with low affinity for antithrombin III to plasma contai
ning UFH increased the anti-IIa activity in a concentration-dependent
fashion by displacing UFH from plasma proteins. In contrast, addition
of low-affinity heparin had no effect on the anti-IIa activity of LMWH
. LMWH does not bind to plasma proteins because the bulk of the LMWH c
hains are <6000 D, and only heparin fractions >6000 D bind nonspecific
ally to plasma proteins. As further evidence that plasma proteins do n
ot influence the anti-IIa activity of LMWH, the rate of thrombin inhib
ition in plasma in the presence of LMWH is virtually identical to that
in buffer containing physiological amounts of the major antithrombins
. In contrast, with UFH or DS, the rate of thrombin inhibition is twof
old slower in plasma than in buffer. Conclusions Nonspecific binding o
f UFH to plasma proteins most likely contributes to the variable anti-
IIa response to UFH in patients with thromboembolic disease. Although
DS also binds to plasma proteins, the clinical significance of this fi
nding is unclear. In contrast, because LMWH does not bind to plasma pr
oteins, the anti-IIa activity of LMWH should be just as predictable as
its anti-Xa activity.